| 摘要 |
<p>Described is use of an active agent selected from the group consisting of leptin, leptin fusion proteins, leptin muteins, leptin receptor agonists, active fragments or fractions of any one thereof, active analogs or derivatives of any one thereof, salts and mixtures of any one thereof for the preparation of a medicament for the treatment of cancer.</p> |
